Aemetis (NASDAQ:AMTX) Rating Increased to Sell at StockNews.com

StockNews.com upgraded shares of Aemetis (NASDAQ:AMTX) to a sell rating in a research note released on Wednesday morning.

A number of other research analysts also recently issued reports on AMTX. Truist Financial reissued a hold rating and issued a $4.00 price objective (up from $3.50) on shares of Aemetis in a research note on Monday, May 13th. HC Wainwright reissued a buy rating and issued a $28.00 price objective on shares of Aemetis in a research note on Friday, May 10th. One equities research analyst has rated the stock with a sell rating, one has assigned a hold rating and three have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of Hold and an average price target of $12.13.

Aemetis Stock Down 6.4 %

Shares of AMTX stock opened at $2.49 on Wednesday. The firm has a market capitalization of $110.56 million, a P/E ratio of -2.13 and a beta of 1.31. Aemetis has a twelve month low of $2.29 and a twelve month high of $7.82. The stock’s fifty day simple moving average is $3.26 and its 200 day simple moving average is $3.69.

Aemetis (NASDAQ:AMTX) last announced its earnings results on Thursday, August 1st. The specialty chemicals company reported ($0.66) EPS for the quarter, missing the consensus estimate of ($0.41) by ($0.25). The business had revenue of $66.56 million during the quarter, compared to analysts’ expectations of $75.37 million. During the same quarter in the previous year, the firm earned ($0.68) earnings per share. As a group, equities research analysts expect that Aemetis will post -1.86 EPS for the current fiscal year.

Insider Activity

In related news, Director John R. Block sold 51,580 shares of the company’s stock in a transaction that occurred on Thursday, May 23rd. The stock was sold at an average price of $3.49, for a total value of $180,014.20. Following the transaction, the director now owns 14,001 shares in the company, valued at $48,863.49. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. 14.34% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On Aemetis

Several institutional investors have recently made changes to their positions in AMTX. Bank of New York Mellon Corp purchased a new stake in shares of Aemetis in the second quarter worth $306,000. Rhumbline Advisers raised its position in shares of Aemetis by 2,837.1% in the second quarter. Rhumbline Advisers now owns 52,309 shares of the specialty chemicals company’s stock worth $157,000 after buying an additional 50,528 shares in the last quarter. State Board of Administration of Florida Retirement System purchased a new stake in shares of Aemetis in the first quarter worth $84,000. Finally, SG Americas Securities LLC purchased a new stake in shares of Aemetis in the first quarter worth $60,000. Hedge funds and other institutional investors own 27.02% of the company’s stock.

Aemetis Company Profile

Aemetis, Inc operates as a renewable natural gas and renewable fuels company. It operates through three segments: California Ethanol, California Dairy Renewable Natural Gas, and India Biodiesel. The company focuses on the operation, acquisition, development, and commercialization of technologies to produce low and negative carbon intensity renewable fuels that replace fossil-based products.